Related Experiment Videos

Vitrectomy in experimental endophthalmitis: Part I-Fungal infection

Ophthalmic Surgery
|March 1, 1979
PubMed

Insights

Amphotericin B effectively treats fungal endophthalmitis in rabbit eyes. Combined with vitrectomy, it clears infections and improves ocular media clarity.

Area of Science:

  • Ophthalmology
  • Mycology
  • Pharmacology

Background:

  • Fungal endophthalmitis poses a significant threat to vision.
  • Amphotericin B is a potent antifungal agent.
  • Vitrectomy is a surgical procedure to remove vitreous humor.

Purpose of the Study:

  • To evaluate the ocular toxicity of amphotericin B.
  • To determine the efficacy of intravitreal amphotericin B in treating fungal endophthalmitis.
  • To assess the combined effect of vitrectomy and amphotericin B.

Main Methods:

  • Dose-related ocular toxicity study of amphotericin B in vitrectomized rabbit eyes.
  • Intravitreal injection of amphotericin B to treat experimentally induced fungal endophthalmitis.
  • Evaluation of combined vitrectomy and intravitreal amphotericin B treatment.

Main Results:

  • Amphotericin B up to 5 micrograms/0.1 ml was non-toxic in vitrectomized eyes.
  • A 2.5 microgram dose of amphotericin B halted fungal endophthalmitis for 16 days.
  • Combined treatment successfully cured fungal endophthalmitis and cleared ocular media opacities.

Conclusions:

  • Intravitreal amphotericin B is a safe and effective treatment for fungal endophthalmitis.
  • Combining vitrectomy with intravitreal amphotericin B offers superior outcomes.
  • This combined approach can restore visual clarity in affected eyes.

Related Concept Videos